# Metabolic FingerPrinting

> **NCT05305729** · — · UNKNOWN · sponsor: **Arcensus GmbH** · enrollment: 10000 (estimated)

## Conditions studied

- Genetic Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05305729
- **Lead sponsor:** Arcensus GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305729, "Metabolic FingerPrinting". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05305729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*